Removal of pharmaceutical residues from wastewater by ozonation and activated carbon has been demonstrated at the Swedish demonstration site Hammarby Sjöstadsverk with promising results for both technologies. Pharmaceuticals are designed to be able to resist microbial degradation, which implies most pharmaceutical substances are still intact when entering wastewater treatment plants and for many alsoRead more →
The R3Water project is funded by the European Commission under the Framework Programme 7. It has started in January 2014 and will run 42 months with a budget of 7.8 M€ co-funded by the European Commission. The consortium, coordinated by IVL Swedish Environmental Research Institute, unites 12 technological partners from seven European countries with involvement of SME’s and RTD centers amongst others.
So far waste water treatment plants are usually regarded as facilities to avoid emissions from wastewater. Current research and development shows that these plants can be converted and upgraded into production units to provide energy, nutrients, water for re-use and possibly other valuables. This is achieved by improved resource efficiency in the plant as well as new technologies and business models that allow the re-use of resources from the incoming water.
The main objective of the project is to demonstrate solutions that support the transition from a treatment plant for urban wastewater to a production unit of different valuables.